Please use this identifier to cite or link to this item:
|Title:||Adenosine Potentiates Human Lung Mast Cell Tissue Plasminogen Activator Activity|
|Authors:||Sereda, Michal J.|
|Publisher:||The American Association of Immunologists, Inc.|
|Citation:||The Journal of Immunology, 2011, 186 (2), pp. 1209-1217|
|Abstract:||We investigated whether adenosine, a potent contributor to the regulation of pulmonary function, can modulate human lung mast cell (HLMC) fibrinolytic activity. Tissue plasminogen activator (tPA) activity and tPA transcript expression levels from a human mast cell line (HMC-1) and HLMC were monitored following adenosine application. Adenosine potentiated mast cell tPA activity and tPA gene expression in a dose-dependent manner. Adenosine effects were abolished in the presence of adenosine deaminase. HMC-1 cells and HLMC predominantly expressed adenosine A2A and A2B receptor transcripts (A2B ≈ A2A > A3 >> A1). Pharmacological and signaling studies suggest that the A2A receptor is the major subtype accounting for adenosine-induced mast cell tPA activity. Finally, the supernatant from HMC-1 cells and HLMC treated with adenosine (for 24 h) significantly increased fibrin clot lysis, whereas ZM241385, an A2A receptor antagonist, abolished this effect. To our knowledge, this study provides the first data to demonstrate the potentiating effect of adenosine on mast cell tPA activity and fibrin clot lysis.|
|Description:||Full text of this item is not currently available on the LRA. The final published version is available at http://www.jimmunol.org/content/186/2/1209, Doi: 10.4049/jimmunol.1001563.|
|Appears in Collections:||Published Articles, Dept. of Cell Physiology and Pharmacology|
Files in This Item:
There are no files associated with this item.
Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.